Cargando…
Overexpression of microRNA-203 can downregulate survivin and function as a potential therapeutic target in papillary thyroid cancer
Papillary thyroid cancer (PTC) is the most common type of thyroid carcinoma. PTC has a considerably high five-year survival rate; however, the possibility of recurrence is also high. Therefore, there is a requirement to clarify the molecular mechanism of PTC to promote understanding regarding the de...
Autores principales: | Wu, Xianjiang, Dai, Lei, Zhang, Zhoujing, Zheng, Jueru, Zhao, Jianpei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924108/ https://www.ncbi.nlm.nih.gov/pubmed/31897115 http://dx.doi.org/10.3892/ol.2019.11082 |
Ejemplares similares
-
LncRNA WT1-AS Downregulates Survivin by Upregulating miR-203 in Papillary Thyroid Carcinoma
por: Le, Fei, et al.
Publicado: (2020) -
MicroRNA‐203a‐3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy
por: Dai, Lei, et al.
Publicado: (2022) -
MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
por: Dai, Lei, et al.
Publicado: (2017) -
Overexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway
por: Xu, Qing, et al.
Publicado: (2016) -
BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer
por: Mao, Langyong, et al.
Publicado: (2015)